Gastric Neoplasm Clinical Trials

6 recruiting

Gastric Neoplasm Trials at a Glance

11 actively recruiting trials for gastric neoplasm are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bethesda, Hong Kong, and Fort-de-France. Lead sponsors running gastric neoplasm studies include National Cancer Institute (NCI), Azienda USL Reggio Emilia - IRCCS, and Azienda Ospedaliera Universitaria Integrata Verona.

Browse gastric neoplasm trials by phase

Treatments under study

About Gastric Neoplasm Clinical Trials

Looking for clinical trials for Gastric Neoplasm? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis

Gastric CancerGastric NeoplasmGastrointestinal Stromal Tumor (GIST)+2 more
National Cancer Institute (NCI)400 enrolled1 locationNCT04557969
Recruiting

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

CholangiocarcinomaPancreas CancerColorectal Neoplasms+2 more
National Cancer Institute (NCI)1,800 enrolled1 locationNCT01915225
Recruiting

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

Stomach NeoplasmsGastric NeoplasmsHelicobacter Pylori
University Hospital Center of Martinique112 enrolled1 locationNCT04949737
Recruiting
Not Applicable

Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy

Artificial IntelligenceGastric Neoplasm
The University of Hong Kong1,000 enrolled1 locationNCT06495645
Recruiting

Endoscopic Resection of Gastrointestinal Neoplasms

Esophageal NeoplasmsColonic NeoplasmsEndoscopic Mucosal Resection+3 more
Azienda USL Reggio Emilia - IRCCS2,000 enrolled1 locationNCT04780256
Recruiting
Not Applicable

Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

Gastric NeoplasmsGastric UlcerGastric Lesion+3 more
Nanfang Hospital, Southern Medical University482 enrolled12 locationsNCT06848400
Recruiting
Phase 1

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

Liver CancerEsophageal CancerGastric Cancer+9 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)18 enrolled1 locationNCT07001592
Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Gastric CancerEsophageal NeoplasmsGastric Adenocarcinoma+6 more
Western Sydney Local Health District500 enrolled1 locationNCT05804331
Recruiting

The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

Gastric CarcinomaGastric Neoplasm
Lin Liu112 enrolled1 locationNCT06702683
Recruiting
Not Applicable

Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy

Gastric CancerGastrointestinal CancerNeoplasms+3 more
Azienda Ospedaliera Universitaria Integrata Verona75 enrolled1 locationNCT06362070
Recruiting

The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer

Gastric CancerGastric NeoplasmsGastric Lesion
EDUARDO ALBENIZ1,200 enrolled15 locationsNCT05551416